During hepatitis C virus (HCV) chronic infection, extrahepatic manifestations are frequent
and polymorphous. This article reports on a large cohort of patients with HCV-related …

Cryoglobulins are immunoglobulins that precipitate in vitro at temperatures less than 37° C
and produce organ damage through two main pathways: vascular sludging (hyperviscosity …

Background Patients with vasculitis induced by the hepatitis C virus (HCV) have reduced
levels of regulatory T cells (Tregs). Resolution of HCV infection correlates with cure of …

Cryoglobulinemic vasculitis (CryoVas) is a small-vessel vasculitis involving mainly the skin,
the joints, the peripheral nervous system, and the kidneys. Type I CryoVas is single …

Hepatitis C virus (HCV) is the most common cause of mixed cryoglobulinemia syndrome
(MCS). The efficacy and safety of all‐oral direct‐acting antiviral (DAA) therapy in HCV …

Recently, the term monoclonal gammopathy of renal significance (MGRS) was introduced to
distinguish monoclonal gammopathies that result in the development of kidney disease from …

Objective To conduct a long‐term, prospective, randomized controlled trial evaluating
rituximab (RTX) therapy for severe mixed cryoglobulinemia or cryoglobulinemic vasculitis …

Hepatitis C virus (HCV) infected patients are known to be at risk of developing liver
complications ie cirrhosis and liver cancer. However, the risks of morbidity and mortality are …

Regression of hepatitis C virus (HCV)–associated lymphoma with interferon (IFN)-based
antiviral treatment supports an etiological link between lymphoma and HCV infection. In …

Background Hepatitis C virus (HCV) is the aetiological agent for most cases of
cryoglobulinaemia vasculitis. Interferon-containing regimens are associated with important …